US Patent Issued to CHIESI FARMACEUTICI on Jan. 20 for "Isochromene derivatives as phosphoinositide 3-kinases inhibitors" (Italian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,797, issued on Jan. 20, was assigned to CHIESI FARMACEUTICI S.p.A. (Parma, Italy).

"Isochromene derivatives as phosphoinositide 3-kinases inhibitors" was invented by Matteo Biagetti (Parma, Italy), Paolo Ronchi (Parma, Italy), Claudio Fiorelli (Parma, Italy) and Paolo Bruno (Parma, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds of formula (I) inhibiting phosphoinositide 3-kinases (PI3K), to pharmaceutical compositions comprising them and therapeutic use thereof in the treatment of disorders associated with PI3K enzymes."

The patent was filed on March 24, 2020, under Application No. 17/600,676.

*For further ...